Abstract
Using a panel of carcinoembryonic antigen (CEA) related antibodies in normal oesophageal squamous mucosa CEA expression is present on suprabasal squames localised to the cell membrane. Immunoblotting shows that this positivity is predominantly due to a glycoprotein of around 180 kDa representing CEA itself.
Positivity in squamous carcinomas is confined to cells in foci of squamous differentiation. A shift from membranous localisation to predominant cytoplasmic overexpression is shown between normal and malignant squames using confocal microscopy. The 
Results

IMMUNOHISTOCHEMISTRY
In normal squamous mucosa CEA related expression was seen on the cell membrane of a broad zone of suprabasal squames with both the polyclonal and monoclonal anti-CEAs. A zone of basal cells was unstained (Fig 1) .
In squamous carcinoma CEA related positivity was seen in cells showing the features of squamous cells at the centre of epithelial 'pearls' (Fig 2) . Little (Fig 3) . In contrast strong predominantly cytoplasmic CEA related fluorescence was seen in CEA expressing cells in squamous carcinoma (Fig 4) . Focal membranous staining was also seen.
IMMUNOBLOTTING
A strong broad CEA related band was seen at around 180 kDa in normal oesophageal squamous mucosa known to represent CEA itself. In contrast bands were seen at around 100 kDa and 160 kDa in neutrophil membrane extract known to represent NCAs7 (Fig 5) .
Discussion
The use of an unabsorbed polyclonal anti-CEA that recognises CEA and NCA in conjunction with monoclonal antibodies, which should be more specific for CEA gives valuable information about CEA related immunoreactivity in paraffin processed tissues.
Immunoblotting permits more precise classification of CEA related expression in a tissue by identifying the molecular weight of the predominant glycoproteins expressed.
We have shown that the predominant CEA related antigen in oesophageal mucosa is a glycoprotein of around 180 kDa known to represent a true CEA. A broad band is seen on immunoblotting because the polyclonal anti-CEA recognises CEAs with subtle differences of glycosylation and hence molecular weight; the core peptide of CEA itself is only 80 kDa, carbohydrate structures accounting for up to 60% of the mass of the mature glycoprotein. Variable glycosylation is also responsible for much of the complex immunogenicity of the CEA superfamily of molecules. CEA of 180 kDa is also expressed in normal cervical squamous mucosa but is slightly higher than that expressed by standard adenocarcinoma (165 kDa). 
